<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04987437</url>
  </required_header>
  <id_info>
    <org_study_id>H-02</org_study_id>
    <nct_id>NCT04987437</nct_id>
  </id_info>
  <brief_title>Prospective Observational Case Series of Primary Hip Arthroplasty With a Short Cemented Stem (Friendly Short)</brief_title>
  <official_title>Prospective Observational Case Series Analysing Outcomes of Primary Hip Arthroplasty With a Short Cemented Stem (Friendly Short)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Limacorporate S.p.a</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Limacorporate S.p.a</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post-marketing observational case series to analyse the functional recover and radiographic&#xD;
      outcomes in terms of implant stability and survivorship of primary hip arthroplasty with&#xD;
      Friendly short cemented stem.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this case series is to verify the functional recover and radiographic outcomes of&#xD;
      primary hip arthroplasty with Friendly short cemented stem.&#xD;
&#xD;
      This is a post-marketing clinical investigation, the product on study is CE marked and used&#xD;
      according to the intended use.&#xD;
&#xD;
      It is a national, mono-centre, prospective, observational case series on 100 patients in 1&#xD;
      site.&#xD;
&#xD;
      Primary endpoint is to investigate clinical progression of patients with THA with Friendly&#xD;
      short stem from baseline to 1-year follow-up.&#xD;
&#xD;
      The secondary endpoint is to evaluate implant stability and survivorship of implants up to 5&#xD;
      years Follow-up.&#xD;
&#xD;
      The evaluation has an internal control because the assessment of post-treatment data is&#xD;
      compared to baseline measurements (pre-operative clinical analysis and radiographic analysis&#xD;
      at discharge).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2, 2011</start_date>
  <completion_date type="Actual">November 6, 2018</completion_date>
  <primary_completion_date type="Actual">December 6, 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>change in percentage of the results of the absolute and weighted (age, gender) Harris Hip Score score from baseline to 1 year</measure>
    <time_frame>up to 5 years FU</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in percentage of the results of the Oxford Hip Score baseline to 1 year</measure>
    <time_frame>up to 5 years FU</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Range Of Motion from baseline to 1 year.</measure>
    <time_frame>up to 5 years FU</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiographic stability</measure>
    <time_frame>up to 5 years FU</time_frame>
    <description>rate of signs of subsidence &gt; 2mm or tilting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of failure</measure>
    <time_frame>up to 5 years FU</time_frame>
    <description>rate or revisions, loosening, failure of cement-stem interface, cement cracks, any definite change in the position of components</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any possible adverse event or complication</measure>
    <time_frame>up to 5 years FU</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Total Hip Arthroplasty</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Friendly short stem</intervention_name>
    <description>Total Hip Arthroplasty with Friendly Short stem</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients requiring a primary hip arthroplasty, due to primary and secondary coxarthrosis,&#xD;
        avascular necrosis, rheumatoid arthritis, neck (but not diaphyseal) fractures&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients of both genders;&#xD;
&#xD;
          -  Patients of all ages, but &gt; 18 years old;&#xD;
&#xD;
          -  Patients with primary and secondary coxarthrosis;&#xD;
&#xD;
          -  Patients with rheumatoid arthritis;&#xD;
&#xD;
          -  Patients with avascular necrosis;&#xD;
&#xD;
          -  Patients with neck (not diaphyseal) fractures;&#xD;
&#xD;
          -  Patients requiring a primary hip arthroplasty.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients requiring a revision of a previous stem;&#xD;
&#xD;
          -  Patients with proven active or suspicious infections;&#xD;
&#xD;
          -  Patients with known hypersensitivity to used materials;&#xD;
&#xD;
          -  Patients with known active neoplastic or metastatic diseases;&#xD;
&#xD;
          -  Patients with significant neurological or musculoskeletal disorders that may affect&#xD;
             functional recover;&#xD;
&#xD;
          -  Patients with proven haemophilic disease;&#xD;
&#xD;
          -  Patients with unwilling or unable to comply with rehabilitation or inability to return&#xD;
             for follow-up visits;&#xD;
&#xD;
          -  Women with pregnancy or childbearing capacity or breast-feeding;&#xD;
&#xD;
          -  Subjects already enrolled in other clinical trials.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Istituto Clinico Sant'Anna</name>
      <address>
        <city>Brescia</city>
        <zip>25127</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 27, 2021</study_first_submitted>
  <study_first_submitted_qc>August 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2021</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

